Biggest News Aggregation in the World
📰 Poster Presentations News

Page 7 - Poster Presentations News Today

Fast, Ad-Free News Updates

Stay updated with breaking news from Poster Presentations. Real-time updates on events, politics, business and more.

Novan Announces Presentation of Two Posters at the 2022 Winter Clinical Dermatology Conference

14.01.2022 - DURHAM, N.C., Jan. 14, 2022 (GLOBE NEWSWIRE) - Novan, Inc. (“the Company” or “Novan”) (Nasdaq: NOVN), today announced that data from the Company’s completed Phase 2 and Phase 3 clinical studies of berdazimer 10.3% gel (previously referred to as ... Seite 1
John Browning Tomoko Maeda Chubachi Carolyn Enloe Elaine Siegfried Martina Cartwright Winter Clinical

Alkermes to Host Webcast With Expert Oncologist Panel to Discuss Data on Nemvaleukin Alfa Presented at 2021 American Society of Clinical Oncology (ASCO) Annual Meeting

- Webcast to be Held at 4:00 p.m. ET on Friday, June 4 - DUBLIN, May 28, 2021 /PRNewswire/ -- Alkermes plc (Nasdaq: ALKS) today announced that it will host a webcast and conference call
United States Valentina Boni Omid Hamid Sandy Coombs Sourojit Bhowmick American Society Of Clinical Oncology

Stay Updated with Latest News

Get breaking news updates delivered to your inbox

Browse All News →

Arch Therapeutics' AC5® Advanced Wound System Presents with Recognition at the 2021 Symposium ...

Press release content from Globe Newswire. The AP news staff was not involved in its creation. Arch Therapeutics’ AC5® Advanced Wound System Presents with Recognition at the 2021 Symposium ... Arch Therapeutics, Inc.May 10, 2021 GMT FRAMINGHAM, Mass., May 10, 2021 (GLOBE NEWSWIRE) -- Arch Therapeutics, Inc. (OTCQB: ARTH) (“Arch” or the “Company”), developer of novel self-assembling wound care and biosurgical devices, presents two clinical case reports supporting the broad potential o...
United States Danielc Wadsworth Daniel Wadsworth Terrencew Norchi Michael Abrams Dermal Sciences
Source: apnews.com

PYC Therapeutics Announces Two Poster Presentations at Association for Research in Vision and Opthalmology (ARVO) 2021 Annual Meeting

PYC Therapeutics Announces Two Poster Presentations at Association for Research in Vision and Ophthalmology (ARVO) 2021 Annual Meeting PYCs PPMO Technology Demonstrates Strong Potential to Overcome Critical Delivery Challenges and Reach Deepest Layers of Retina in Patient-Derived Models Modulation of Gene Expression to Upregulate PRPF31 and Rescue Retinitis Pigmentosa Type 11 Disease Phenotypes Achieved in Patient-Derived Models News provided by Share this article Share this article NEW YORK an...
Western Australia Phosphorodiamidate Morpholino Oligomer Janya Grainok Group Leader Association For Research Professor Sue Fletcher

Immutep To Announce New TACTI-002 and INSIGHT-004 Data in Poster Presentations and Discussion at the ASCO 2021 Annual Meeting

Search jobs 30-Apr-2021 Immutep To Announce New TACTI-002 and INSIGHT-004 Data in Poster Presentations and Discussion at the ASCO 2021 Annual Meeting Immutep To Announce New TACTI-002 and INSIGHT-004 Data in Poster Presentations and Discussion at the ASCO 2021 Annual Meeting   SYDNEY, AUSTRALIA – 29 April 2021 – Immutep Limited (ASX: IMM; NASDAQ: IMMP) ("Immutep” or “the Company”), the leading developer of LAG-3 related immunotherapy treat...
Western Australia United States Israel General New South Wales Frankfurt Am Main Comunidad Autonoma De Cataluna

Ultragenyx Announces Upcoming Data Presentations at American Society of Gene & Cell Therapy 2021 Virtual Annual Meeting

Ultragenyx Announces Upcoming Data Presentations at American Society of Gene & Cell Therapy 2021 Virtual Annual Meeting April 27, 2021 17:47 ET | Source: Ultragenyx Pharmaceutical Inc. Ultragenyx Pharmaceutical Inc. Novato, California, UNITED STATES NOVATO, Calif., April 27, 2021 (GLOBE NEWSWIRE) -- Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE), a biopharmaceutical company focused on the development and commercialization of novel therapies for rare ...
University Of Pennsylvania United States United Kingdom Joshua Higa Nicholas Richards Barbaraa Sullivan

Eisai Presents Breadth of Data Across Neurology Portfolio, Including Alzheimer's Disease, Insomnia and Epilepsy

Eisai Presents Breadth of Data Across Neurology Portfolio, Including Alzheimers Disease, Insomnia and Epilepsy Twenty-one presentations featuring data and information on investigational lecanemab in early Alzheimers disease, DAYVIGO® (lemborexant) CIV in insomnia, FYCOMPA® (perampanel) CIII in epilepsy and investigational lorcaserin in Dravet Syndrome News provided by Share this article Share this article WOODCLIFF LAKE, N.J., April 16, 2021 /PRNewswire/ -- Eisai Inc., the U.S. pharmaceutical...
United States New Jersey North Carolina Gary Zammit Shau Yu Lynch Alzheimers Dement

Explore More Categories

World News India News Business Technology Sports Entertainment Health Science